Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Irschik

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Antibiotics|September 1, 1995
Ratjadon: a new antifungal compound from Sorangium cellulosum (myxobacteria) production, physio-chemical and biological propertiesK Gerth, D Schummer, G Höfle, et al.
The Journal of Antibiotics|August 1, 1988
Saframycin Mx1, a new natural saframycin isolated from a myxobacteriumH Irschik, W Trowitzsch-Kienast, K Gerth, et al.
Wiener Klinische Wochenschrift|November 8, 1985
[Individual dialysis using computer-controlled prescription]J Kovarik, H Graf, H Irschik, et al.
The Journal of Antibiotics|August 1, 1982
Pyrrolnitrin from Myxococcus fulvus (Myxobacterales)K Gerth, W Trowitzsch, V Wray, et al.
Transplantation Proceedings|December 1, 1995
Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipientsR Klauser, H Irschik, J Kletzmayr, et al.
Contributions to Nephrology|January 1, 1985
Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term resultsJ Kovarik, H Irschik, H Graf, et al.
Transplantation Proceedings|November 20, 1997
Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: does fat intake still matter?R M Klauser, H Irschik, J Kletzmayr, et al.
The Journal of Antibiotics|September 1, 1983
The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of actionK Gerth, R Jansen, G Reifenstahl, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Antibiotics|September 1, 1995
Ratjadon: a new antifungal compound from Sorangium cellulosum (myxobacteria) production, physio-chemical and biological propertiesK Gerth, D Schummer, G Höfle, et al.
The Journal of Antibiotics|August 1, 1988
Saframycin Mx1, a new natural saframycin isolated from a myxobacteriumH Irschik, W Trowitzsch-Kienast, K Gerth, et al.
Wiener Klinische Wochenschrift|November 8, 1985
[Individual dialysis using computer-controlled prescription]J Kovarik, H Graf, H Irschik, et al.
The Journal of Antibiotics|August 1, 1982
Pyrrolnitrin from Myxococcus fulvus (Myxobacterales)K Gerth, W Trowitzsch, V Wray, et al.
Transplantation Proceedings|December 1, 1995
Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipientsR Klauser, H Irschik, J Kletzmayr, et al.
Contributions to Nephrology|January 1, 1985
Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term resultsJ Kovarik, H Irschik, H Graf, et al.
Transplantation Proceedings|November 20, 1997
Pharmacokinetic cyclosporine A profiles under long-term Neoral treatment in renal transplant recipients: does fat intake still matter?R M Klauser, H Irschik, J Kletzmayr, et al.
The Journal of Antibiotics|September 1, 1983
The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of actionK Gerth, R Jansen, G Reifenstahl, et al.
Pageof 3